PDF(Pubmed)
Abstract：
UNASSIGNED: Minimal Clinically Important Difference (MCID) and Patient-Acceptable Symptomatic State (PASS) have emerged as patient-based treatment assessments. However, these have not been investigated in patients undergoing arthroscopic isolated subscapularis repair (AISR). The primary purpose of this study was to determine the MCID and PASS for commonly used patient-reported outcomes in individuals who underwent AISR. The secondary purpose was to assess potential associations between preoperative and intraoperative patient characteristics and the MCID and PASS.
UNASSIGNED: A retrospective analysis was conducted on prospectively collected data for patients who underwent primary AISR between 2011 and 2021 at a single institution, with minimum 2-year postoperative follow-up. Functional outcomes were assessed using the American Shoulder and Elbow Surgeons (ASES) score, Subjective Shoulder Value (SSV), and Visual Analog Scale (VAS) pain scale. The MCID was determined using the distribution-based method, while PASS was evaluated using area under the curve analysis. To investigate the relationship between preoperative variables and the achievement of MCID and PASS thresholds, Pearson and Spearman coefficient analyses were employed for continuous and noncontinuous variables, respectively.
UNASSIGNED: A total of 77 patients with a mean follow-up of 58.1 months were included in the study. The calculated MCID values for VAS pain, ASES, and SSV were 1.2, 10.2, and 13.2, respectively. The PASS values for VAS pain, ASES, and SSV were 2.1, 68.8, and 68, respectively. There was no significant correlation between tear characteristics and the likelihood of achieving a MCID or PASS. Female sex, worker\'s compensation status, baseline VAS pain score, and baseline ASES score, exhibited weak negative correlations for achieving PASS for VAS pain and ASES.
UNASSIGNED: This study defined the MCID and PASS values for commonly used outcome measures at short-term follow-up in patients undergoing AISR. Tear characteristics do not appear to impact the ability to achieve a MCID or PASS after AISR. Female sex, worker\'s compensation claim, and low baseline functional scores have weak negative correlations with the achievement of PASS for VAS pain and ASES scores.
UNASSIGNED: A retrospective analysis was conducted on prospectively collected data for patients who underwent primary AISR between 2011 and 2021 at a single institution, with minimum 2-year postoperative follow-up. Functional outcomes were assessed using the American Shoulder and Elbow Surgeons (ASES) score, Subjective Shoulder Value (SSV), and Visual Analog Scale (VAS) pain scale. The MCID was determined using the distribution-based method, while PASS was evaluated using area under the curve analysis. To investigate the relationship between preoperative variables and the achievement of MCID and PASS thresholds, Pearson and Spearman coefficient analyses were employed for continuous and noncontinuous variables, respectively.
UNASSIGNED: A total of 77 patients with a mean follow-up of 58.1 months were included in the study. The calculated MCID values for VAS pain, ASES, and SSV were 1.2, 10.2, and 13.2, respectively. The PASS values for VAS pain, ASES, and SSV were 2.1, 68.8, and 68, respectively. There was no significant correlation between tear characteristics and the likelihood of achieving a MCID or PASS. Female sex, worker\'s compensation status, baseline VAS pain score, and baseline ASES score, exhibited weak negative correlations for achieving PASS for VAS pain and ASES.
UNASSIGNED: This study defined the MCID and PASS values for commonly used outcome measures at short-term follow-up in patients undergoing AISR. Tear characteristics do not appear to impact the ability to achieve a MCID or PASS after AISR. Female sex, worker\'s compensation claim, and low baseline functional scores have weak negative correlations with the achievement of PASS for VAS pain and ASES scores.
摘要：
■最小临床重要差异（MCID）和患者可接受的症状状态（PASS）已成为基于患者的治疗评估。然而,在接受关节镜下孤立肩胛骨下修复(AISR)的患者中,尚未对这些患者进行过研究.本研究的主要目的是确定接受AISR的患者中常用患者报告结果的MCID和PASS。次要目的是评估术前和术中患者特征与MCID和PASS之间的潜在关联。
■对2011年至2021年在单一机构接受原发性AISR的患者的前瞻性收集数据进行了回顾性分析，术后随访至少2年。使用美国肩肘外科医生（ASES）评分评估功能结果，主观肩值(SSV),和视觉模拟量表（VAS）疼痛量表。MCID是使用基于分布的方法确定的，而PASS使用曲线下面积分析进行评估。为了探讨术前变量与MCID和PASS阈值之间的关系，对连续变量和非连续变量采用皮尔逊和斯皮尔曼系数分析，分别。
■共纳入77例患者，平均随访58.1个月。计算的VAS疼痛的MCID值，ASES,SSV分别为1.2、10.2和13.2。VAS疼痛的PASS值,ASES,SSV分别为2.1、68.8和68。泪液特性与达到MCID或PASS的可能性之间没有显著相关性。女性性别,工人的补偿状态，基线VAS疼痛评分，和基线ASES评分，对于VAS疼痛和ASES达到PASS表现出弱的负相关。
■本研究定义了接受AISR的患者在短期随访中常用结局指标的MCID和PASS值。撕裂特性似乎不会影响AISR后实现MCID或PASS的能力。女性性别,工人的赔偿要求，低基线功能评分与VAS疼痛的PASS和ASES评分的实现呈弱负相关。
■对2011年至2021年在单一机构接受原发性AISR的患者的前瞻性收集数据进行了回顾性分析，术后随访至少2年。使用美国肩肘外科医生（ASES）评分评估功能结果，主观肩值(SSV),和视觉模拟量表（VAS）疼痛量表。MCID是使用基于分布的方法确定的，而PASS使用曲线下面积分析进行评估。为了探讨术前变量与MCID和PASS阈值之间的关系，对连续变量和非连续变量采用皮尔逊和斯皮尔曼系数分析，分别。
■共纳入77例患者，平均随访58.1个月。计算的VAS疼痛的MCID值，ASES,SSV分别为1.2、10.2和13.2。VAS疼痛的PASS值,ASES,SSV分别为2.1、68.8和68。泪液特性与达到MCID或PASS的可能性之间没有显著相关性。女性性别,工人的补偿状态，基线VAS疼痛评分，和基线ASES评分，对于VAS疼痛和ASES达到PASS表现出弱的负相关。
■本研究定义了接受AISR的患者在短期随访中常用结局指标的MCID和PASS值。撕裂特性似乎不会影响AISR后实现MCID或PASS的能力。女性性别,工人的赔偿要求，低基线功能评分与VAS疼痛的PASS和ASES评分的实现呈弱负相关。
